181 related articles for article (PubMed ID: 22553414)
1. Major Functional Transcriptome of an Inferred Center Regulator of an ER(-) Breast Cancer Model System.
Liu LY; Chang LY; Kuo WH; Hwa HL; Lin YS; Huang SF; Chen CN; Chang KJ; Hsieh FJ
Cancer Inform; 2012; 11():87-111. PubMed ID: 22553414
[TBL] [Abstract][Full Text] [Related]
2. Prognostic features of signal transducer and activator of transcription 3 in an ER(+) breast cancer model system.
Liu LY; Chang LY; Kuo WH; Hwa HL; Lin YS; Jeng MH; Roth DA; Chang KJ; Hsieh FJ
Cancer Inform; 2014; 13():21-45. PubMed ID: 24526833
[TBL] [Abstract][Full Text] [Related]
3. SHCBP1 regulates STAT3/c-Myc signaling activation to promote tumor progression in penile cancer.
Mo M; Tong S; Yin H; Jin Z; Zu X; Hu X
Am J Cancer Res; 2020; 10(10):3138-3156. PubMed ID: 33163262
[TBL] [Abstract][Full Text] [Related]
4. Interaction between STAT3 and GLI1/tGLI1 oncogenic transcription factors promotes the aggressiveness of triple-negative breast cancers and HER2-enriched breast cancer.
Sirkisoon SR; Carpenter RL; Rimkus T; Anderson A; Harrison A; Lange AM; Jin G; Watabe K; Lo HW
Oncogene; 2018 May; 37(19):2502-2514. PubMed ID: 29449694
[TBL] [Abstract][Full Text] [Related]
5. Genomic regulation of invasion by STAT3 in triple negative breast cancer.
McDaniel JM; Varley KE; Gertz J; Savic DS; Roberts BS; Bailey SK; Shevde LA; Ramaker RC; Lasseigne BN; Kirby MK; Newberry KM; Partridge EC; Jones AL; Boone B; Levy SE; Oliver PG; Sexton KC; Grizzle WE; Forero A; Buchsbaum DJ; Cooper SJ; Myers RM
Oncotarget; 2017 Jan; 8(5):8226-8238. PubMed ID: 28030809
[TBL] [Abstract][Full Text] [Related]
6. TRIB3 Interacts with STAT3 to Promote Cancer Angiogenesis.
Chen QZ; Chen Y; Li X; Liu H; Sun XL
Curr Med Sci; 2022 Oct; 42(5):932-940. PubMed ID: 36245025
[TBL] [Abstract][Full Text] [Related]
7. Stat3/Oct-4/c-Myc signal circuit for regulating stemness-mediated doxorubicin resistance of triple-negative breast cancer cells and inhibitory effects of WP1066.
Cheng CC; Shi LH; Wang XJ; Wang SX; Wan XQ; Liu SR; Wang YF; Lu Z; Wang LH; Ding Y
Int J Oncol; 2018 Jul; 53(1):339-348. PubMed ID: 29750424
[TBL] [Abstract][Full Text] [Related]
8. Stat3 Tyrosine 705 and Serine 727 Phosphorylation Associate With Clinicopathological Characteristics and Distinct Tumor Cell Phenotypes in Triple-Negative Breast Cancer.
Stenckova M; Nenutil R; Vojtesek B; Coates PJ
Pathol Oncol Res; 2022; 28():1610592. PubMed ID: 36017196
[TBL] [Abstract][Full Text] [Related]
9. [Activation and prognostic significance of AKT, NF-kappaB and STAT3 in breast cancer with lymph node metastasis and estrogen receptor expression].
Liu C; Zhou S; Ke CS; Li NP; Wu RL
Ai Zheng; 2007 Sep; 26(9):929-36. PubMed ID: 17927847
[TBL] [Abstract][Full Text] [Related]
10. The targetable nanoparticle BAF312@cRGD-CaP-NP represses tumor growth and angiogenesis by downregulating the S1PR1/P-STAT3/VEGFA axis in triple-negative breast cancer.
Gong K; Jiao J; Xu C; Dong Y; Li D; He D; Zhao D; Yu J; Sun Y; Zhang W; Bai M; Duan Y
J Nanobiotechnology; 2021 May; 19(1):165. PubMed ID: 34059068
[TBL] [Abstract][Full Text] [Related]
11. STAT3 as a potential therapeutic target in triple negative breast cancer: a systematic review.
Qin JJ; Yan L; Zhang J; Zhang WD
J Exp Clin Cancer Res; 2019 May; 38(1):195. PubMed ID: 31088482
[TBL] [Abstract][Full Text] [Related]
12. HMGA1 promotes breast cancer angiogenesis supporting the stability, nuclear localization and transcriptional activity of FOXM1.
Zanin R; Pegoraro S; Ros G; Ciani Y; Piazza S; Bossi F; Bulla R; Zennaro C; Tonon F; Lazarevic D; Stupka E; Sgarra R; Manfioletti G
J Exp Clin Cancer Res; 2019 Jul; 38(1):313. PubMed ID: 31311575
[TBL] [Abstract][Full Text] [Related]
13. VEGF drives cancer-initiating stem cells through VEGFR-2/Stat3 signaling to upregulate Myc and Sox2.
Zhao D; Pan C; Sun J; Gilbert C; Drews-Elger K; Azzam DJ; Picon-Ruiz M; Kim M; Ullmer W; El-Ashry D; Creighton CJ; Slingerland JM
Oncogene; 2015 Jun; 34(24):3107-19. PubMed ID: 25151964
[TBL] [Abstract][Full Text] [Related]
14. TrkA Interacts with and Phosphorylates STAT3 to Enhance Gene Transcription and Promote Breast Cancer Stem Cells in Triple-Negative and HER2-Enriched Breast Cancers.
Regua AT; Aguayo NR; Jalboush SA; Doheny DL; Manore SG; Zhu D; Wong GL; Arrigo A; Wagner CJ; Yu Y; Thomas A; Chan MD; Ruiz J; Jin G; Strowd R; Sun P; Lin J; Lo HW
Cancers (Basel); 2021 May; 13(10):. PubMed ID: 34066153
[TBL] [Abstract][Full Text] [Related]
15. Phosphorylated STAT3 (Tyr705) as a biomarker of response to pimozide treatment in triple-negative breast cancer.
Dees S; Pontiggia L; Jasmin JF; Mercier I
Cancer Biol Ther; 2020 Jun; 21(6):506-521. PubMed ID: 32164483
[TBL] [Abstract][Full Text] [Related]
16. Stat3 and c-Myc genome-wide promoter occupancy in embryonic stem cells.
Kidder BL; Yang J; Palmer S
PLoS One; 2008; 3(12):e3932. PubMed ID: 19079543
[TBL] [Abstract][Full Text] [Related]
17. Stat3 regulates ErbB-2 expression and co-opts ErbB-2 nuclear function to induce miR-21 expression, PDCD4 downregulation and breast cancer metastasis.
Venturutti L; Romero LV; Urtreger AJ; Chervo MF; Cordo Russo RI; Mercogliano MF; Inurrigarro G; Pereyra MG; Proietti CJ; Izzo F; Díaz Flaqué MC; Sundblad V; Roa JC; Guzmán P; Bal de Kier Joffé ED; Charreau EH; Schillaci R; Elizalde PV
Oncogene; 2016 Apr; 35(17):2208-22. PubMed ID: 26212010
[TBL] [Abstract][Full Text] [Related]
18. Crosstalk of mTOR/PKM2 and STAT3/c-Myc signaling pathways regulate the energy metabolism and acidic microenvironment of gastric cancer.
Gao S; Chen M; Wei W; Zhang X; Zhang M; Yao Y; Lv Y; Ling T; Wang L; Zou X
J Cell Biochem; 2019 Feb; 120(2):1193-1202. PubMed ID: 30417413
[TBL] [Abstract][Full Text] [Related]
19. Nobiletin Inhibits Angiogenesis by Regulating Src/FAK/STAT3-Mediated Signaling through PXN in ER⁺ Breast Cancer Cells.
Sp N; Kang DY; Joung YH; Park JH; Kim WS; Lee HK; Song KD; Park YM; Yang YM
Int J Mol Sci; 2017 Apr; 18(5):. PubMed ID: 28468300
[TBL] [Abstract][Full Text] [Related]
20. In Silico Prediction for Regulation of Transcription Factors onTheir Shared Target Genes Indicates Relevant Clinical Implications in a Breast Cancer Population.
Liu LY; Chang LY; Kuo WH; Hwa HL; Shyu MK; Chang KJ; Hsieh FJ
Cancer Inform; 2012; 11():113-37. PubMed ID: 22553415
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
